The investigations into the role of FGF23 in cancer have so far revealed two important aspects in general: In those forms of cancer affecting bone or originating from it such as MM or prostate cancer, FGF23 signaling may directly contribute to cancer biology/progression. The gene discussed is FGF23; the disease is Miyoshi myopathy.